{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 460"}, "official-title": {"#tail": "\n\t", "#text": "To amend title XXVII of the Public Health Service Act to\n\t\t  limit co-payment, coinsurance, or other cost-sharing requirements applicable to\n\t\t  prescription drugs in a specialty drug tier to the dollar amount (or its\n\t\t  equivalent) of such requirements applicable to prescription drugs in a\n\t\t  non-preferred brand drug tier, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130204", "#text": "February 4, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. McKinley", "@name-id": "M001180"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mrs. Capps", "@name-id": "C001036"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Capito", "@name-id": "C001047"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Young of Florida", "@name-id": "Y000031"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Moran", "@name-id": "M000933"}, {"#tail": ", ", "#text": "Mr. Wolf", "@name-id": "W000672"}, {"#tail": ", ", "#text": "Mr. Tonko", "@name-id": "T000469"}, {"#tail": ", ", "#text": "Mr.\n\t\t\t Runyan", "@name-id": "R000594"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Conyers", "@name-id": "C000714"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Bonamici", "@name-id": "B001278"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Cicilline", "@name-id": "C001084"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. DeFazio", "@name-id": "D000191"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Michaud", "@name-id": "M001149"}, {"#tail": ", ", "#text": "Mr. Farr", "@name-id": "F000030"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Pingree of Maine", "@name-id": "P000597"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Rangel", "@name-id": "R000053"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Crenshaw", "@name-id": "C001045"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H291C196D6A7F49F8BE4D1263F9176243", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Patients\u2019 Access to Treatments Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H0BF352CBC51343DFAF57AB52258BD5DC"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Cost-sharing\n\t\t\t requirements applicable to prescription drugs in a specialty drug tier"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Subpart II of part A\n\t\t\t of title XXVII of the Public Health Service Act", "@value": "Public Health Service Act/t:XXVII/pt:A/spt:II"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 300gg et seq.", "@value": "usc/42/300gg/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "2719B."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Cost-sharing\n\t\t\t\trequirements applicable to prescription drugs in a specialty drug tier"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "A\n\t\t\t\tgroup health plan, or a health insurance issuer offering group or individual\n\t\t\t\thealth insurance, that provides coverage for prescription drugs and uses a\n\t\t\t\tformulary or other tiered cost-sharing structure shall not impose cost-sharing\n\t\t\t\trequirements applicable to prescription drugs in a specialty drug tier that\n\t\t\t\texceed the dollar amount (or its equivalent) of cost-sharing requirements\n\t\t\t\tapplicable to prescription drugs in a non-preferred brand drug tier (or\n\t\t\t\tprescription drugs in a brand drug tier if there is no non-preferred brand drug\n\t\t\t\ttier)."}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Requirement"}, "#text": "\n              ", "@id": "H5E191DE53A354E99876A7F1CB0BAD474"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall be applied with respect to the non-preferred brand drug tier for which\n\t\t\t\tbeneficiary cost-sharing is lowest.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Public Health Service Act/s:2719B/ss:a", "@proposed": "true"}, "#text": "If a formulary used by a group health plan or a health\n\t\t\t\tinsurance issuer offering group or individual health insurance contains more\n\t\t\t\tthan one non-preferred brand drug tier, then the requirements of "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Special\n\t\t\t\trule"}, "#text": "\n              ", "@id": "H46C62FC406244BA8B3F6AA3560E7D218"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In this section:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " includes co-payment and coinsurance.", "#text": "cost-sharing"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "HB3BDE2311F6F46BA9FC633487CFE01A5", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to a group health plan or health\n\t\t\t\tinsurance issuer offering group or individual health insurance coverage that\n\t\t\t\tuses a formulary or other cost-sharing structure, a category of drugs\u2014", "#text": "drug tier"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H12C027F4D5BF483BAAEB6B4788F2EF8D", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "within such\n\t\t\t\tformulary or structure for which the total dollar amount of cost-sharing\n\t\t\t\trequirements for any drug does not vary by more than ten percent from the total\n\t\t\t\tdollar amount of cost-sharing requirements for any other drug; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HFE43488F535B482882487F1C4A286EC8", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\tprescription drugs."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H4EA7E806CF6B4C4CADC0DF7300944567", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to a group\n\t\t\t\thealth plan or health insurance issuer offering group or individual health\n\t\t\t\tinsurance coverage that uses a formulary or other tiered cost-sharing\n\t\t\t\tstructure, a category of drugs\u2014", "#text": "non-preferred brand drug tier"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "#text": "\n                ", "@id": "H0392C2B993414AF5B9B665A0CC0302E8", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "within a drug tier in such formulary or\n\t\t\t\tstructure for which beneficiary cost-sharing is greater than drug tiers for\n\t\t\t\tgeneric drugs or preferred brand drugs in the formulary or structure;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HCBA06120B2404162B2E4A54B83DD0A41", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\tprescription drugs; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HD739C39DCE3A44D9A26305234E621A04", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that are not\n\t\t\t\tincluded within a specialty drug tier."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H941F4EC307B649ADA9F4ACB4CC8A70DC", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "prescription drug"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "@id": "HA2D46E9B3370417BAC49EA48918A9005", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 503(b)(1) of the Federal Food, Drug, or Cosmetic Act", "@value": "Federal Food, Drug, or Cosmetic Act/s:503/ss:b/p:1"}, "#text": "a drug subject to\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HD6DB3E19AAF24BBDBE18D4A986BB1C87", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that is a biological product (as defined in\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Public Health Service Act/s:2719B/ss:c/p:4/sp:A", "@proposed": "true"}, {"#tail": ").", "@entity-type": "act", "#text": "section 351(i) of this Act", "@value": "Public Health Service Act/s:351/ss:i"}], "#text": "includes a drug\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HEB582B2691734E96A7D31A24E27688C1", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to a group health plan or\n\t\t\t\thealth insurance issuer offering group or individual health insurance coverage\n\t\t\t\tthat uses a formulary or other tiered cost-sharing structure, a category of\n\t\t\t\tdrugs\u2014", "#text": "specialty drug tier"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "#text": "\n                ", "@id": "H4AEBE430F51340BE82CD4D986760934A", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "within a drug tier in such formulary or\n\t\t\t\tstructure for which beneficiary cost-sharing is greater than drug tiers for\n\t\t\t\tgeneric drugs, preferred brand drugs, or non-preferred drugs in the plan\u2019s\n\t\t\t\tformulary; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H271A65C3272846A2B448E65BC18C3804", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\tprescription\n\t\t\t\tdrugs."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H43C12DF8F3B04EE9AC3DDC350C5221C8", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "H4833924F8E2C46CBB09AFBF743C84A9A"}], "#text": "\n            ", "@id": "H44961867F4914BFD94FD2BBB06C3C530"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HCB04BB30BAFC451897705A7C65280FBD"}, "#text": "\n        ", "@id": "HF20A42F24D3442AEB5E84D5D4AC4C5C5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by\n\t\t\t ", "@entity-type": "act", "#text": "Section 2719B of the Public Health Service Act", "@value": "Public Health Service Act/s:2719B"}, {"#tail": ", applies to plan years beginning on or after the date of the\n\t\t\t enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Patients' Access to Treatments Act of 2013/s:2/ss:a", "@proposed": "true"}], "#text": "\n          "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "HA1A831C9A11744249ECD2795B39E1232"}], "#text": "\n      ", "@id": "H9B023CBC47494D5B9817A070E06C5272"}], "#text": "\n\t\t", "@id": "H7FD80E8C9B2C4A23BCEEC56C550D0AFE"}}}